For a lot of transgender people, starting hormone replacement therapy feels like finally getting the keys to a body that makes sense. Naturally, most of the early conversation revolves around what happens next.
When will my skin change? When will my breasts grow? When will my voice change? What happens to my muscles? My hair? My libido? My emotions?
There are timelines, charts, and endless social media posts documenting the first month, first year, and first few years of hormone therapy. But there is another question that receives considerably less attention: What happens after 10, 20, or 30 years?
What does estrogen therapy look like when a trans woman reaches 60, 70, or 80? What happens when a trans man who started testosterone at 22 reaches retirement age? Should hormone doses automatically decrease? Does cardiovascular risk change? What about bones, cancer screening, or sexual health?
Those questions are becoming increasingly important as more transgender people openly grow older while receiving gender-affirming hormone therapy.
And medicine doesn’t have every answer yet.
That doesn’t mean long-term HRT is inherently dangerous. It means transgender healthcare is entering territory where decades of high-quality longitudinal research remain limited. For patients and clinicians, the challenge is learning how to manage ordinary aging alongside gender-affirming care rather than treating the two as competing priorities.
HRT Was Never Supposed to Have an Expiration Date
One misconception worth killing immediately is the idea that transgender people eventually have to “age out” of hormone therapy. There is no universal birthday when someone suddenly becomes too old for gender-affirming hormones.
Instead, hormone therapy should be evaluated the same way many other long-term medications are evaluated: by considering the individual patient’s goals, medical history, current health, medications, and changing risk factors.
Someone who started estrogen at 25 may have a very different health profile at 65. That’s normal. Cisgender people’s healthcare changes with age too.
Blood pressure may increase. Cholesterol may change. Bone density can decline. Metabolism changes. New medications appear in the bathroom cabinet like Pokémon you never wanted to collect.
The appropriate response isn’t necessarily to abandon HRT. It’s to reassess the entire health picture.
Your Hormone Goals May Change
Early transition can involve relatively aggressive efforts to achieve desired hormone ranges and physical changes. Decades later, the priorities may be different.
Some people may want to maintain the same regimen indefinitely. Others may prefer lower doses as they age. Medical conditions may require changing the route of administration rather than eliminating hormone therapy entirely.
For example, clinicians may consider whether oral, injectable, or transdermal estrogen is most appropriate based on someone’s individual cardiovascular and clotting risks.
That decision shouldn’t be reduced to “older equals less estrogen.” Age is one factor among many.
Smoking history, blood pressure, cholesterol, diabetes, family history, previous blood clots, body composition, physical activity and other medications can matter too.
Most importantly, hormone treatment remains gender-affirming healthcare even when you’re 72 instead of 22. Older transgender adults aren’t former transgender people.
The Heart Question
Cardiovascular health is one of the biggest concerns surrounding long-term hormone therapy, particularly estrogen.
Research suggests that gender-affirming hormones can influence cardiovascular risk factors, including cholesterol, blood pressure, body composition and insulin sensitivity. Some studies have also identified increased risks of certain cardiovascular events among particular transgender populations.
But translating population-level findings into an individual’s risk isn’t simple.
A trans woman who exercises regularly, doesn’t smoke, has normal blood pressure, and receives routine preventive care isn’t medically interchangeable with someone who smokes, has uncontrolled hypertension, and hasn’t seen a primary-care clinician in eight years.
This is where routine healthcare matters.
- Blood pressure should be checked.
- Cholesterol should be monitored.
- Diabetes risk should be assessed.
- Smoking cessation should be encouraged.
- Exercise should be treated as medicine without turning every appointment into a lecture about weight.
And clinicians should look at the whole patient instead of reflexively pointing at the estrogen prescription whenever anything goes wrong. Aging on HRT requires cardiovascular awareness, not cardiovascular panic.
Bones Quietly Become a Bigger Deal
Nobody thinks much about bone density when they’re 25. Your skeleton is just there, doing skeleton things. Unfortunately, bones become considerably more interesting when they stop cooperating.
Both estrogen and testosterone play important roles in maintaining bone health. That makes adequate hormone exposure particularly important for transgender people who have undergone a gonadectomy.
A person who no longer produces substantial amounts of endogenous sex hormones and then stops HRT for an extended period could potentially place their bone health at risk.
Age adds another layer.
Bone density naturally becomes a greater concern as people get older, especially when additional risk factors are present. Those can include smoking, low vitamin D, inadequate calcium intake, low body weight, certain medications, limited physical activity, and a history of fractures.
Resistance training can help. So can adequate nutrition. And for some people, bone-density testing may eventually become appropriate. This is another reason the simplistic advice to “just stop hormones when you’re older” doesn’t make much medical sense.
Hormones aren’t merely cosmetic. They interact with multiple systems throughout the body.
Muscle Changes Matter Too
Body composition changes are among the most noticeable effects of gender-affirming hormone therapy. Feminizing HRT generally reduces lean muscle mass over time, while testosterone therapy generally increases it.
Then aging enters the chat.
Adults naturally tend to lose muscle mass and strength as they get older, a process that can eventually contribute to sarcopenia, reduced mobility, and increased fall risk.
For older transgender women, particularly those who have already experienced significant reductions in muscle mass during transition, preserving functional strength can become increasingly important. That doesn’t mean trying to rebuild the physique you had before transition.
It means keeping enough muscle to carry groceries, climb stairs, get off the floor, protect your joints, and remain independent. Resistance training is especially valuable here. And no, lifting weights isn’t going to cancel your estrogen. Muscle is not masculine. Muscle is useful.
Cancer Screening Needs to Follow Anatomy
One of the recurring failures in transgender healthcare is trying to force every patient into a male or female screening template.
A better approach is remarkably straightforward: Screen the organs that are actually present. A trans woman who retains her prostate still has a prostate. A trans man who retains a cervix still has a cervix.
People with breast tissue may need breast cancer screening depending on age, anatomy, hormone exposure, and individual risk factors. Someone who has undergone certain gender-affirming surgeries may require different screening or follow-up.
Electronic medical records aren’t always brilliant at understanding this. Neither are automated reminders.
That means transgender patients sometimes have to advocate for preventive screenings that computer systems don’t think they need. As transgender people age, fixing that gap becomes increasingly important because cancer screening becomes a larger part of routine preventive medicine.
Sexual Health Doesn’t Retire Either
Older adults have sex. Yes, even transgender ones. We’ll give everyone who finds that revelation shocking a moment to recover.
Hormone therapy, aging, surgeries, medications, and chronic medical conditions can all affect libido and sexual function.
Estrogen therapy may influence erectile function, genital tissue, and libido. Testosterone can affect vaginal tissues and may contribute to dryness or discomfort for some people. Menopause-like genitourinary symptoms, pelvic health, and urinary issues can also become relevant depending on someone’s anatomy and treatment history.
None of this should automatically be treated as the inevitable price of getting older. There may be treatment options. More importantly, clinicians need to actually ask. Sexual health remains healthcare, whether someone is 27 or 77.
Medication Lists Get Longer
One practical complication of aging is that HRT may eventually become one medication among several.
- Blood-pressure medications.
- Cholesterol medication.
- Diabetes treatment.
- Antidepressants.
- Pain medication.
- Thyroid medication.
- Blood thinners.
Suddenly the pill organizer has developed its own supporting cast. That makes periodic medication reviews increasingly important.
For example, spironolactone can affect potassium levels and kidney function, which may become more relevant when someone develops kidney disease or begins taking other medications that also affect potassium.
Other health changes may influence whether a particular hormone formulation remains the best option. Again, the answer isn’t automatically stopping HRT. Sometimes the solution is adjusting the dose, changing the delivery method, replacing an anti-androgen or simply monitoring something more closely.
What About Menopause?
This is where transgender healthcare becomes particularly interesting. Cisgender women typically experience menopause because ovarian hormone production declines. A trans woman receiving estrogen does not experience that same biological process.
But that doesn’t mean aging on estrogen is irrelevant. Should estrogen doses decrease with age to resemble hormone levels after menopause in cisgender women? For some patients, perhaps.
For everyone? There isn’t strong evidence supporting a universal rule.
The decision may depend on symptoms, bone health, cardiovascular risk, surgical history, and personal goals. Some transgender women may strongly prefer maintaining estrogen because of its physical and psychological benefits. Others may be comfortable reducing their dose.
That conversation should happen between the patient and a knowledgeable clinician rather than being dictated by an arbitrary birthday.
The Research Gap Is Real
This may be the most important part of the conversation. Modern transgender medicine has improved enormously, but researchers still don’t have the kind of long-term data available for many other areas of medicine.
We need studies following transgender people across decades. We need better research involving people who started HRT at different ages. We need more information about cardiovascular outcomes, cancer, cognition, bone density, sexual health, and medication interactions. And we desperately need research involving older transgender adults themselves.
Too much transgender health research historically focused either on transition outcomes or on whether gender-affirming treatment was “safe.”
Those are important questions. But they’re not the only questions. We also need to know how transgender people can age well.
The Bottom Line
One day, the transgender healthcare conversation has to move beyond puberty blockers, coming-out stories, and the first few years of HRT. Because transgender people are getting older. That’s a victory worth acknowledging.
Many generations of transgender people lived during periods when discrimination, violence, HIV/AIDS, inadequate healthcare, and social isolation dramatically shortened lives.
Growing old while openly transgender wasn’t always something people could safely imagine. Now more people can, and that means medicine needs to catch up.
Aging on HRT shouldn’t be approached as a countdown toward eventually surrendering gender-affirming healthcare. It should mean adjusting healthcare as the body changes.
- Check the heart.
- Protect the bones.
- Maintain muscle.
- Screen the anatomy that’s actually there.
- Review medications.
- Talk about sexual health.
- Monitor hormones.
And make decisions based on the individual sitting in the examination room rather than an M or F buried somewhere in a medical record. The goal isn’t merely helping transgender people transition. It’s helping transgender people live. And if we’re lucky, that means helping a whole lot more of us become wonderfully, unapologetically old.
Medical Disclaimer: This article is for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Gender-affirming hormone therapy should be individualized based on your health history, medications, anatomy, goals, and risk factors. Do not stop, reduce, increase, or otherwise change your hormone medications based solely on information in this article. Talk with a qualified healthcare professional about your HRT regimen, recommended screenings, laboratory testing, and any new or concerning symptoms.
